Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

Medtronic Signia SDR Product Surveillance Registry

ClinicalTrials.gov ID: NCT05095935

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05095935. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Medtronic Signia Small Diameter Reload Product Surveillance Registry

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the registry is to confirm the safety and performance of the Signia™ Small Diameter Reload (SDR) when used in surgical procedures in a real-world setting in patients receiving surgery for indicated thoracic, abdominal, and pediatric applications, intraoperatively.

Study identification

NCT ID
NCT05095935
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Medtronic
Industry
Enrollment
430 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 10, 2021 (Actual)
Primary completion
Oct 1, 2024 (Actual)
Completion
Oct 1, 2024 (Actual)
Last update posted
Jan 7, 2026

2021 – 2024

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Cedars Sinai Medical Center Los Angeles California 90048 —
Children's Hospital Colorado Denver Colorado 80045 —
The George Washington University Hospital Washington D.C. District of Columbia 20037 —
Rush Chicago Illinois 60612 —
Cooper Health System Camden New Jersey 08103 —
NYU Langone Medical Center New York New York 10016 —
New York Presbyterian Hospital - Colombia University Medical Center New York New York 10032 —
UNC Chapel Hill Chapel Hill North Carolina 27599 —
Duke University Health Systems Durham North Carolina 27705 —
Cleveland Clinic Cleveland Ohio 44195 —
UPMC Falk Clinic Pittsburgh Pennsylvania 15213 —
University of Texas - San Antonio San Antonio Texas 78249 —
Virginia Cancer Specialists Fairfax Virginia 22031 —
Mary Washington Hopital Fredericksburg Virginia 22401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05095935, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 7, 2026 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.